Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-23

Clinical Trial Update: Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating acetaminophen to reduce oxidative injury in severe sepsis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen (Acetaminophen)

Snippet

Sponsor: Vanderbilt University | Conditions: Severe Sepsis | Phase 2 | Status: COMPLETED | Results posted: 2015-03-23